According to GlobalData’s medical device pipeline database, 18 Primary Hip Replacement devices are in various stages of development globally. GlobalData’s report Primary Hip Replacement provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 11 are in active development, while the remaining seven are in an inactive stage of development. There are two products in the early stages of development, and the remaining nine are in the late stages of development.
Orthopedic devices are medical devices that are used to treat or prevent musculoskeletal disorders. Primary Hip Replacement is a surgical procedure which involves total replacement of a damaged hip joint by prostheses During the procedure, the damaged ball and socket of the hip joint are removed and replaced with artificial joint components. The implants include prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum, and an acetabular resurfacing component made of ultra-high molecular weight polyethylene (in metal or plastic) or alloy, such as cobalt-chromium-molybdenum (in metal on metal) During Primary Cemented Hip Replacement procedure, the implant is attached to the bone with the help of cement In a Primary Cementless Hip Replacement procedure, the implant is attached to the bone directly without using cement In a Primary Hybrid Hip Replacement procedure, one component (acetabular/femoral) is inserted with cement and the other component is inserted without cement.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Primary Hip Replacement pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Primary Hip Replacement devices. Overall, most of these Primary Hip Replacement pipeline devices are being developed by private entities.
Key players involved in the active development of Primary Hip Replacement include JRI Orthopaedics, MicroPort Orthopedics, Smith & Nephew, University of Maine, University of Oxford, University of Oxford, University of Warwick, MicroPort Scientific, SINTX Technologies and Corin Group.
For a complete picture of the developmental pipeline for Primary Hip Replacement devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.